By employing an angiogenic ELISA assay and Western blot analysis, we also confirmed that APX3330 treatment significantly decreases the expression of inflammatory factors such as MCP1, MMP9 and RAGE and pro-thrombotic factor PAI-1, in the ischemic brain of T1DM stroke rats. The gene discussed is SERPINE1; the disease is stroke disorder.